(Q40680333)

22 September 2017

Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy (English)

1 reference

22 September 2017

0 references

1 reference

1 reference

6

1 reference

22 September 2017

12

1 reference

22 September 2017

Marc Humbert

9

0 references

Xavier Mariette

14

object named as

Xavier Mariette

1 reference

22 September 2017

Jérémie Sellam

1

1 reference

22 September 2017

Haifa Hamdi

2

1 reference

22 September 2017

Carine Roy

3

1 reference

22 September 2017

Gabriel Baron

4

1 reference

22 September 2017

Marc Lemann

5

1 reference

22 September 2017

Maxime Breban

7

1 reference

22 September 2017

Francis Berenbaum

8

1 reference

22 September 2017

Karin Weldingh

10

1 reference

22 September 2017

Dominique Salmon

11

1 reference

22 September 2017

Dominique Emilie

13

1 reference

22 September 2017

RATIO (Research Axed on Tolerance of Biotherapies) Study Group

15

1 reference

22 September 2017

language of work or name

English

0 references

publication date

24 April 2007

1 reference

Annals of the Rheumatic Diseases

22 September 2017

1 reference

22 September 2017

66

1 reference

22 September 2017

12

1 reference

22 September 2017

1610-1615

1 reference

Antituberculosis drugs and hepatotoxicity

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Adverse reactions to first-line antituberculosis drugs

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

TNF-blocking agents and tuberculosis: new drugs illuminate an old topic

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

22 September 2017

The tuberculin skin test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

QuantiFERON TB Gold Test: the new standard for screening of latent tuberculosis in patients with rheumatoid arthritis?

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Early diagnosis of subclinical multidrug-resistant tuberculosis.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and anti-tumour necrosis factor inhibitors

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Diagnosing latent tuberculosis infection: the 100-year upgrade

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Priorities for the Treatment of Latent Tuberculosis Infection in the United States

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095326

Recommendations about the prevention and management of tuberculosis in patients taking infliximab

2 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17456528

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Use of commercial interferon-gamma assays in immunocompromised patients for tuberculosis diagnosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17456528

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tuberculosis in the cytokine era: what rheumatologists need to know

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17456528

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ARD.2007.069799

1 reference

22 September 2017

1 reference

22 September 2017

PubMed publication ID

17456528

1 reference